RE:At Some Point...biloshi wrote: Vanc will become profitable.
This sector especially in the OTC area has decent margins!
Take BioSyent (V.RX) trading at $9.00 per share and a market cap of $126.6M with most of that on the back of one OTC product. RX has approx 14m shares out and EPS of 26 cents!
Cheers!
I beleive at some point it will become profitable as well. However, at the present time, there is still risk in this play. The company needs to continue to make in roads with pharmacies who will sell product. It is a competitive business, hence all the marketing incentives up to date. Slowly, Vanc will need to reduce these incentives as their customer relationships strengthen. The key here is to make sure they have product available when someone orders it! So relationships with suppliers is important too. Hopefully, Q3 numbers will show improvement.
Next is to fix that website!! I beleive a previous poster mentioned the website "sucks".... and they are 100% right on that.
I think Vanc needs to start building strong relationships with shareholders as well. Even if things are not progressing as quickly as they want to, they just need to be honest and share info with shareholders. IR definetely needs improvement! But, from what I hear, the AGM went fairly well... so all baby steps!
Oh ya.... and then there are the NDA's. So some things can be shared, and some can't!
I am long and below water at the moment, but will continue to hold and add to my position once harvest is over.
Good Luck Everyone! One day, I think this stock will be worth the wait! But that is the key - waiting!
FI4